Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

0
Player Avatar targetphil (52.21) Submitted: 7/29/2009 10:29:33 PM : Outperform Start Price: $9.84 CRTX Score: -83.08

feelin FOOLISH!

Featured Broker Partners


Advertisement